EPHA2 and urinary bladder carcinoma: In bladder cancer cells progranulin stimulated Akt- and Erk1/2-mediated EphA2 phosphorylation at Ser897 and EphA2 depletion attenuated proliferation and cisplatin resistance [134], mimicking progranulin depletion [89].